LIVE
4.4M influencer listings 🏢50.9K sponsor listings 🌍69B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.8M Bluesky creators 🎙️1.2M podcast creators 🟣807.5K Twitch creators 🐘158.6K Mastodon creators 🥊105K Kick creators ▶️83.1K YouTube creators 𝕏80.9K X creators 📈74.2K Pinterest creators ✈️56.5K Telegram creators 🎵35.9K TikTok creators 🎮8.3K Discord creators 🎬4.1K Rumble creators 📈2.2K Substack creators 🧵1.6K Threads creators 4.4M influencer listings 🏢50.9K sponsor listings 🌍69B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.8M Bluesky creators 🎙️1.2M podcast creators 🟣807.5K Twitch creators 🐘158.6K Mastodon creators 🥊105K Kick creators ▶️83.1K YouTube creators 𝕏80.9K X creators 📈74.2K Pinterest creators ✈️56.5K Telegram creators 🎵35.9K TikTok creators 🎮8.3K Discord creators 🎬4.1K Rumble creators 📈2.2K Substack creators 🧵1.6K Threads creators
The Lancet

The Lancet

🔄 Data last refreshed 10 days ago
🤝

Make a deal with The Lancet

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Every booking is a normal escrow-protected deal.

Followers
22.3K
Account age
1 yrs
🎁 Free analysisfor The Lancet

Known for

📊 Post engagement

10
Avg engagement / post
0%
Engagement vs followers
Nov 2024
On Bluesky since

🔥 Top post: More people are ageing with HIV than ever before. A new Commiss · 20 likes + reposts

📊 Activity & format

Posting cadence
10.5 / week
Posts daily — consistently active for a campaign window.
Content mix
Mostly images
Recent: 2 text · 10 image · 0 video.
Follower / following
399×
Follows 56 back. A strong ratio — an audience that follows them, not a follow-for-follow network.

Recent posts

View on Bluesky ↗
🔥 Top post More people are ageing with HIV than ever before. A new Commission in The Lancet HIV calls for HIV care that supports healthy ageing through better prevention, person-centred care, & stronger health systems: tinyurl.com/32y4yez7 #IAS2026 #AIDS2026 @iasociety.bsky.social ★ 20
"One of the biggest stories this week wasn't about a drug. It was about something far more familiar..." Lancet authors join our Editors to discuss highlights from #AAIC2026 & what excites them about the future of Alzheimer's Disease & dem… ★ 4 Amyloidosis care has changed dramatically in the last decade. New therapies, better diagnosis, and multidisciplinary collaboration have improved outcomes—but access remains unequal. What can other rare diseases learn from this progress? … ★ 10 In our latest issue, the first major dementia-prevention study in Latin America finds that a structured healthy-lifestyle programme boosts memory and thinking in at-risk older adults. Find out more: spkl.io/633227K7ww #AAIC2026 ★ 8 Psoriasis is a common, chronic skin disease affecting more than 60 million individuals worldwide. In a new Seminar, authors provide an updated survey of current knowledge on psoriasis, its clinical management, and key future challenges: s… ★ 8 Bloodstream-delivered cell therapy slows muscle decline in young people with Duchenne muscular dystrophy, phase 3 trial finds. Explore the research 👉 spkl.io/633207KSdn ★ 8 Mental disorders are leading contributors to disease burden among young people. A new study in @lancetrh-wpac.bsky.social provides current estimates of prevalence, patterns, severity, and profiles of mental disorders among Australians age… ★ 9 Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial spkl.io/633257KRAX ★ 4 Blood pressure and cholesterol levels in adults over 40 with obesity increasingly similar to adults with normal BMI, study suggests in The Lancet. Explore the research 👉 spkl.io/633297JLZN ★ 11 New Review—Inherited retinal degenerations: clinical phenotypes and emerging therapies spkl.io/633297JLRh ★ 10 Who owns cardiometabolic disease? Many people with interconnected conditions navigate multiple clinics and care plans. Our latest Editorial discusses whether it's time to rethink how cardiometabolic care is organised. Read more: spkl.io/… ★ 9 On the cover, a new Comment explores the intersection between climate, war, and the global health-care supply chain. Read this & more: spkl.io/633237JL1x ★ 15

🦋 Handle & authenticity

✅ Domain-verified
@thelancet.com
The handle is the domain thelancet.com. On Bluesky a domain handle proves the owner controls that website — so this is verifiably the real thelancet.com account, not an impersonator.
On Bluesky since
Nov 2024
Joined after Bluesky opened to the public — a settled account with a real history.

💡 Facts

🗓️Joined Bluesky in 2024 — 1 year ago.
👁️Averages 10 views per post.
📤Posts about 10.5× per week.
🏅Earned the 10K Followers for passing 10K followers.

🕵️ Fake follower check

Estimated
53/100
Fair Credibility score
76%
Mixed Real audience
Medium Fake-follower risk
High Data confidence
  • Est. 76% real, active audience · Medium fake-follower risk.
  • Low engagement (~0.0% of followers engage each post) — a sign of an inflated or inactive audience.
  • Organic base — far more followers than accounts it follows.
  • Verified account.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823. 🌐 thelancet.com

📸 Gallery

✉ Message The Lancet

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with The Lancet

Booking an event / appearance is a Pro feature. Upgrade to book The Lancet for an in-person or virtual appearance — payment held safely in escrow until the event is done.

See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from Bluesky's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove